Bioxcel Therapeutics, Inc. · NASDAQ:BTAI
Mehta Vimal sold 19,419 Bioxcel Therapeutics, Inc. shares (Form 4)
Traded May 4 to May 20, 2026 · Filed May 22, 2026
From May 4 to May 20, 2026, Mehta Vimal (Director, CEO and President) sold 19,419 Bioxcel Therapeutics, Inc. shares at US$1.09 for US$21,167 under a trading plan, leaving 69,598 shares. Filed May 22, 2026 (Form 4).
- Sold
- 19,419 shares
- Price
- US$1.09
- Value
- US$21,167
- Holding after
- 69,598 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director, CEO and President
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 4, 2026 | Common Stock | Option exercise | 49,758 | 89,017 | Direct | |
| May 20, 2026 | Common Stock | Sale | 19,419 | US$1.09 | 69,598 | Direct |
Source
Related
- Bioxcel Therapeutics, Inc.
- Mehta Vimal
- Bioxcel Therapeutics, Inc. shareholders
- Form 4 · Mehta Vimal · Jun 17, 2026
- Form 4 · Mehta Vimal · May 7, 2026
- Schedule 13G/A · Armistice Capital, LLC · Aug 14, 2026
- Form 4 · Rodriguez Javier · Jun 17, 2026
- Form 4 · Steinhart Richard I · Jun 17, 2026
- Form 4 · Yocca Frank · Jun 17, 2026
- Form 4 · Yocca Frank · May 22, 2026